Global Next Gen Sequencing Market Size and Overview

Next gen sequencing is also known as high-throughput sequencing includes several mode
sequencing technologies such as Illumina (Solexa), Roche 454 sequencing, Ion torrent: Proton/PGM sequencing, and SOLiD sequencing. The applications of next gen sequencing in diagnostics include illnesses such as cancer, neurology, psychiatry, dysmorphology, cardiology, vision & hearing impairment, and pharmacogenomics.  

Advantages such as cost-effectiveness and broad range of functional applications of genomics have widely driven the next gen sequencing market. However, increasing conce
s of legal and ethical issues hamper the market growth to a significant extent.

The next gen sequencing market is segmented on the basis of type, product, end user, application, and geography. Whole genome sequencing, targeted resequencing, whole exome sequencing, RNA sequencing, CHIP sequencing, De Novo sequencing, and methyl sequencing are analyzed in the segmentation by type. Further, the products studied in the report include instrument, reagent & consumable, and services. Based on end user, the next gen sequencing market is segmented into hospitals, academics, and biotech & pharmaceutical firms. By application, the market is segmented into drug discovery, genetic screening, diagnostics, agriculture & animal research, and others. Geographically, the next gen sequencing market is sub-divided into North America, Europe, Asia-Pacific, and Rest of the world.

The key market players operating in the next gen sequencing market include Agilent Technologies., DNASTAR Inc., F. Hoffmann-La Roche Ltd., GATC Biotech AG., Illumina Inc., Macrogen Inc., Pacific Biosciences of Califo
ia Inc., PerkinElmer Inc., Qiagen., and Thermo Fisher Scientific Inc. among others.

NEXT GEN SEQUENCING MARKET SEGMENTS

Market By Type

•    Whole Genome Sequencing

•    Targeted Resequencing

•    Whole Exome Sequencing

•    RNA Sequencing

•    CHIP Sequencing

•    De Novo Sequencing

•    Methyl Sequencing

Market By Product

•    Instruments

•    Reagents and Consumables

•    Services

Market By End User

•    Hospitals

•    Academics

•    Biotech and Pharmaceutical Firms

Market By Application

•    Drug Discovery/Personalized Medicine

•    Genetic Screening

•    Diagnostics/Infectious Diseases

•    Agriculture and Animal Research

•    Others

Market By Geography

•    North America

•    Europe

•    Asia Pacific

•    Rest of the world

KEY PLAYERS

•    Agilent Technologies.

•    DNASTAR Inc.

•    F. Hoffmann-La Roche Ltd.

•    GATC Biotech AG.

•    Illumina Inc.

•    Macrogen Inc.

•    Pacific Biosciences of Califo
ia Inc.

•    PerkinElmer Inc.

•    Qiagen.

•    Thermo Fisher Scientific Inc.